Di Wu

Di Wu

Auto-generated profile, based on publicly available information

Di Wu

Department of Urology, Huadong Hospital Affiliated to Fudan University, Shanghai, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Theranostics
Verified
Journal Article
Open access
DWDi Wu
Di Wu
ZZZi-Qiang Zhu
Zi-Qiang Zhu
HTHai-Xiao Tang
Hai-Xiao Tang
ZSZhi-En Shi
Zhi-En Shi
JKJian Kang
Jian Kang
JQJun Qi
Jun Qi
Rationale: Prostate cancer has become one of the most threatening malignant tumors in men, leading to an imperative need to develop effective and safe therapies. Because of the unique metabolism of tumor cells, the tumor microenvironment (TME) exhibits distinctive properties compared with normal tissues, among which the pH difference has been utilized as an ideal antitumor strategy. Herein, we introduce a reactive oxygen species (ROS)-controlled-release nanosystem with TME-responsiveness by applying hollow mesoporous silica nanoparticles (HMSNs) as carriers loaded with calcium peroxide (CaO2) and coated with polyacrylic acid (PAA) to construct the functional material CaO2@HMSNs-PAA. The differences in pH values and exogenous ROS scavenging abilities between the tumor tissue and normal tissues and the dual pH-responsiveness from CaO2 and PAA lay a scientific foundation for the application of CaO2@HMSNs-PAA in the tumor-selective therapy for prostate cancer.

8 July 2020 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
TJTian Jin
Tian Jin
DWDi Wu
Di Wu
XLXiao-Ming Liu
Xiao-Ming Liu
JXJiang-Tao Xu
Jiang-Tao Xu
BMBing-Jie Ma
Bing-Jie Ma
KMKe Ma
Ke Ma
Background: Celastrol has been proven effective in anti-inflammatory but was limited in the clinic due to the poor solubility and side effects induced by low bioavailability. Osteoarthritis has acidic and inflammatory environment. Our aim was to load celastrol into HMSNs and capped with chitosan to construct a pH-responsive nanoparticle medicine (CSL@HMSNs-Cs), which is of high solubility for osteoarthritis intra-articular injection treatment. Methods: The CSL@HMSNs-Cs were assembled and the characteristics were measured. The CSL@HMSNs-Cs was applied in vitro in the chondrocytes collected from rats cartilage tissue and in vivo in the MIA induced knee osteoarthritis rats via intra-articular injection. Cytotoxicity assay, pH-responsive release, pain behavior, MRI, safranin o fast green staining, ELISA and western blot analysis were applied to evaluate the bioavailability and therapeutic effect of CSL@HMSNs-Cs. Results: CSL@HMSNs-Cs was stable due to the protection of the chitosan layers in alkaline environment (pH = 7.7) but revealed good solubility and therapeutic effect in acidic environment (pH = 6.0). The cytotoxicity assay showed no cytotoxicity at relatively low concentration (200 μg/mL) and the cell viability of chondrocytes stimulated by IL-1β was increased in CSL@HMSNs-Cs group. Paw withdrawal threshold in CSL@HMSNs-Cs group is increased, and MRI and Safranin O Fast Green staining showed improvements in articular surface erosion and joint effusion. The upregulated expression levels of IL-1β, TNF-α, IL-6, MMP-3 and MMP-13 and NF-κB signaling pathway of chondrocytes were inhibited in CSL@HMSNs-Cs group. Conclusion: Hollow mesoporous silica nanoparticles were an ideal carrier for natural drugs with poor solubility and were of high biocompatibility for intra-articular injection. These intra-articular injectable CSL@HMSNs-Cs with improved solubility, present a pH-responsive therapeutic strategy against osteoarthritis.


1 May 2026 in Translational Andrology and Urology
Verified
Journal Article
Open access
PDF file
DWDong-Ya Wang
Dong-Ya Wang
JWJian-Hong Wu
Jian-Hong Wu
ZSZhi-Yuan Shen
Zhi-Yuan Shen
ZZZhong-Yun Zhang
Zhong-Yun Zhang
DWDi Wu
Di Wu
Background: Hydronephrosis is a serious long-term complication of benign prostatic hyperplasia (BPH), and patients with this condition are prone to suffer from renal insufficiency. This study was performed to evaluate the efficacy of holmium laser enucleation of the prostate (HoLEP) for renal dysfunction in BPH patients with hydronephrosis. Methods: In this retrospective cohort study, the enrolled 122 patients were divided into two groups according to the type of surgery: HoLEP (n=64) or bipolar plasmakinetic transurethral resection of the prostate (TURP, n=58). Perioperative indicators and follow-up variables were analysed to evaluate the efficacy and durability of HoLEP. Results: The HoLEP group had a shorter operation time, bladder irrigation time, catheterization duration and hospital stays; less haemoglobin (Hb) and sodium decrease; and greater tissue removal (P<0.01). Improvements in the International Prostate Symptom Score (I-PSS), postvoid residual, maximum urinary flow rate, hydronephrosis and renal dysfunction in the HoLEP group were more evident during the entire follow-up period (P<0.01). Conclusions: Therefore, by more safely and completely removing the hyperplastic prostate tissue to ensure durable relief of lower urinary tract obstruction, HoLEP can effectively and continuously benefit the recovery of renal function in BPH patients with preoperative hydronephrosis, and it is expected to become the ideal surgical intervention for these patients.